Home/Filings/4/0001209191-19-040985
4//SEC Filing

GOLD DANIEL P PHD 4

Accession 0001209191-19-040985

CIK 0001262104other

Filed

Jul 2, 8:00 PM ET

Accepted

Jul 3, 3:35 PM ET

Size

5.5 KB

Accession

0001209191-19-040985

Insider Transaction Report

Form 4
Period: 2019-07-01
GOLD DANIEL P PHD
DirectorPresident and Chief Executive
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-07-01+680,000680,000 total
    Exercise: $2.52Exp: 2029-07-01Common Stock (680,000 underlying)
Footnotes (1)
  • [F1]One-quarter of such Options shall vest on July 1, 2020 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2020.

Issuer

MEI Pharma, Inc.

CIK 0001262104

Entity typeother

Related Parties

1
  • filerCIK 0001288233

Filing Metadata

Form type
4
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 3:35 PM ET
Size
5.5 KB